PMV Pharmaceuticals, Inc.

PMVP
$1.19 (+ $0.04 + 3.48%)
Last updated: 2026-06-27 14:58 UTC
PMVP Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS69353Y1038
CUSIP69353Y103
Market Price1.19
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.6
Market Cap$64.9M
Book Value2.28
Price to Book0.534
Beta1.64
52w High1.84
52w Low0.81
Next Earnings DateN/A

PMV Pharmaceuticals, Inc. trades under ticker PMVP on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US69353Y1038, CUSIP 69353Y103.

About the Company
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Price History